Mobility Promotion for Cardiovascular Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if increasing physical activity in hospitalized patients with heart problems can enhance their overall health. A kinesiologist will encourage daily activities like walking and standing to help reduce frailty, which measures overall health, and potentially shorten hospital stays. The trial will compare results between males and females to assess any differences in benefits. Ideal participants include those with a major heart issue, likely to stay in the hospital for three or more days, and able to communicate in French or English. As an unphased trial, this study offers participants the chance to contribute to important research that could improve hospital care for heart patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this mobilization program is safe for inpatients with cardiovascular disease?
Research shows that increased physical activity in individuals with heart problems can be safe and beneficial. Studies have found that exercise reduces the risk of heart attacks and hospital visits for both men and women with heart issues. Regular activities, such as walking or using resistance bands, improve heart health and decrease the likelihood of worsening heart problems.
Exercise programs are associated with fewer deaths and less severe heart conditions. Active individuals have a lower risk of dying from any cause, including heart disease. This suggests that promoting movement in hospitals is generally safe and aids in the recovery of patients with heart problems.12345Why are researchers excited about this trial?
Researchers are excited about mobility promotion for cardiovascular disease because it offers a fresh approach by incorporating daily kinesiologist visits to encourage physical activity. Unlike standard treatments that often rely on medications and lifestyle advice, this method actively engages patients in movement, helping them maximize their physical capabilities through regular, personalized interactions. This hands-on approach not only aims to improve cardiovascular health but also enhances overall mobility and quality of life, potentially leading to better long-term outcomes for patients.
What evidence suggests that this mobility promotion program is effective for reducing frailty in cardiovascular patients?
Research has shown that encouraging movement can help people with heart disease. Studies have found that cardiac rehabilitation, which includes exercise, lowers the risk of heart attacks and reduces hospital visits. Increased activity in those with heart issues is linked to shorter hospital stays and better health. Wearable devices that track activity can enhance these benefits by motivating more movement. Overall, promoting movement improves heart health and reduces frailty, a measure of overall health, in patients. In this trial, a team of kinesiologists will visit participants daily to promote movement and help them mobilize to the best of their capabilities.12678
Are You a Good Fit for This Trial?
This trial is for male and female inpatients with cardiovascular disease who are at risk of frailty. Participants must have a major heart problem, be expected to stay in the hospital for at least 3 days, and be able to give consent independently. The study aims to include 60 patients (30 females).Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a mobilization program with daily check-ins by a Kinesiologist to promote movement and reduce frailty
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Mobility promotion
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Sherbrooke
Lead Sponsor
Vitalite Health Network
Collaborator